These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4275093)

  • 1. Fibrinogenolysis by insolubilized plasmin.
    Matthias FR; Krause W; Heene DL
    Clin Chim Acta; 1974 Mar; 52(1):91-6. PubMed ID: 4275093
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolysis and fibrinogenolysis by Val442-plasmin.
    Ney KA; Pizzo SV
    Biochim Biophys Acta; 1982 Nov; 708(2):218-24. PubMed ID: 6216916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of fibrin degradation products in patients on ancrod therapy: comparison with fibrinogen derivatives produced by plasmin.
    Prentice CR; Edgar W; McNicol GP
    Br J Haematol; 1974 May; 27(1):77-87. PubMed ID: 4277400
    [No Abstract]   [Full Text] [Related]  

  • 4. Immobilized human plasmins: preparation and enzymatic properties.
    Chibber BA; Leadbetter MG; Mertz ET
    Prep Biochem; 1974; 4(4):315-30. PubMed ID: 4280068
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of the lysine binding sites of human plasmin in the hydrolysis of human fibrinogen.
    Morris JP; Castellino FJ
    Biochim Biophys Acta; 1983 Apr; 744(1):99-104. PubMed ID: 6219709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of L-arginine on in vitro plasmin-generation and fibrinogenolysis.
    Udvardy M; Posán E; Palatka K; Altorjay I; Harsfalvi J
    Thromb Res; 1997 Jul; 87(1):75-82. PubMed ID: 9253802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin(-ogen) interactions with plasmin.
    Gaffney PJ
    Haemostasis; 1977; 6(1):2-25. PubMed ID: 140113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of fibrinogen in vitro. Demonstration of several antigenic intermediates by specific anti-D and anti-E serum.
    Gormsen J; Feddersen C; Clemmensen I; Andersen RB
    Scand J Haematol; 1972; 9(6):577-86. PubMed ID: 4118846
    [No Abstract]   [Full Text] [Related]  

  • 9. Physicochemical and biological properties of human and canine plasmins.
    Takeda Y; Nakabayashi M
    J Clin Invest; 1974 Jan; 53(1):154-62. PubMed ID: 4128408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of adsorbed fibrinogen by surface-generated plasmin.
    Brash JL; Chan BM; Szota P; Thibodeau JA
    J Biomed Mater Res; 1985; 19(9):1017-29. PubMed ID: 2935535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo behavior of the terminal derivatives of fibrinogen and fibrin cleaved by plasmin.
    Catanzaro A; Edgington TS
    J Lab Clin Med; 1974 Mar; 83(3):458-66. PubMed ID: 4272970
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study of fibrinogenolysis of adult and cord vein fibrinogen (author's transl)].
    Hafter R; Wallenstätter R; Graeff H
    Hoppe Seylers Z Physiol Chem; 1981 Feb; 362(2):175-8. PubMed ID: 6452398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex formation between fibrinogen, fibrinogen degradation products and insolubilized fibrin monomer at various pH values.
    Matthias FR
    Haemostasis; 1973-1974; 2(6):277-80. PubMed ID: 4802436
    [No Abstract]   [Full Text] [Related]  

  • 16. Digestion of amidinated and phenylglyoxal treated fibrinogen by plasmin.
    Kang EP; Triantaphyllopoulos DC
    Thromb Res; 1976 Sep; 9(3):261-6. PubMed ID: 136057
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation and characterization of NH2-terminal fibrinogen B beta fragments from N-DSK of human fibrinogen.
    Birken S; Agosto G; Lahiri B; Canfield R
    Thromb Haemost; 1984 Feb; 51(1):16-21. PubMed ID: 6232727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differentiation between fibrinogenolysis and fibrinolysis products induced by plasmin].
    Maki M
    Nihon Ketsueki Gakkai Zasshi; 1967 Apr; 30(2):267-75. PubMed ID: 4229020
    [No Abstract]   [Full Text] [Related]  

  • 20. Degradation of fibrinogen by plasmin: physicochemical characteristics and their correlation to antithrombic activity.
    Triantaphyllopoulos E
    Thromb Diath Haemorrh Suppl; 1973; 56():91-112. PubMed ID: 4281941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.